Bayer | BAYN - Interest Expense On Debt



Bayer reported 495M in Interest Expense on Debt for its fiscal quarter ending in June of 2025.


Interest Expense On Debt Change Date
Air Liquide 129.5M 600K Jun/2025
Akzo Nobel EUR 68M 26M Jun/2025
Alcon AG USD 49M 1000K Mar/2025
Amarin USD 3K 3K Dec/2024
Arkema 593M 576M Dec/2022
AstraZeneca 303M 126M Jun/2025
BASF EUR 222M 4M Jun/2025
Bayer 495M 89M Jun/2025
Beiersdorf EUR 7.5M 4.5M Jun/2025
Corteva USD 52M 16M Jun/2025
Covestro EUR 39M 6M Sep/2024
Essilor EUR 147M 102.5M Jun/2025
Fresenius 86M 30M Jun/2025
Fresenius Medical Care EUR 96.58M 15.58M Jun/2025
Genmab DKK 9M 4M Jun/2025
Givaudan CHF 28M 28M Jun/2024
GlaxoSmithKline 184M 22M Jun/2025
GRIFOLS EUR 202.71M 94.07M Jun/2024
Henkel EUR 26.5M 22.5M Jun/2025
Hikma Pharmaceutical 22M 9M Jun/2024
Linde 68M 3M Sep/2024
Lonza CHF 70M 11M Dec/2024
Merck 79M 1000K Jun/2025
Novartis USD 289M 19M Jun/2025
Nutrien 155M 24M Jun/2025
Philips 80M 24M Jun/2025
PPG Industries USD 62M 6M Jun/2025
Roche Holding CHF 311.5M 1000K Dec/2024
Sanofi 148M 65M Jun/2025
SAP EUR 268M 12M Jun/2025
Solvay EUR 25M 0 Jun/2025
UCB 108M 16M Dec/2024
Umicore 36.5M 33.15M Dec/2024
Vinci EUR 661M 69M Jun/2025